Guest Open Access | Free Content | About | Sign in | New Users: Sign up | Mark List  

 

Current Pharmaceutical Biotechnology

Volume 9 Issue 3
ISSN: 1389-2010

 

   All Titles

  Eosinophil-Derived Neurotoxin / RNase 2: Connecting the Past, the Present and the Future
  pp.135-140 (6) Author: H. F. Rosenberg
 
 
      Abstract

The eosinophil-derived neurotoxin (EDN, also known as eosinophil protein-X) is best-known as one of the four major proteins found in the large specific granules of human eosinophilic leukocytes. Although it was named for its discovery and initial characterization as a neurotoxin, it is also expressed constitutively in human liver tissue and its expression can be induced in macrophages by proinflammatory stimuli. EDN and its divergent orthologs in rodents have ribonuclease activity, and are members of the extensive RNase A superfamily, although the relationship between the characterized physiologic functions and enzymatic activity remains poorly understood. Recent explorations into potential physiologic functions for EDN have provided us with some insights into its role in antiviral host defense, as a chemoattractant for human dendritic cells, and most recently, as an endogenous ligand for toll-like receptor (TLR)2.

 
  Keywords: Inflammation, Ribonuclease, Toll-like receptor, Dendritic cell, Leukocyte
  Affiliation: Laboratory of Allergic Diseases, Building 10, Room 11C215, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, USA.
 
  Key: New Content Free Content Open Access Subscribed Content

 
Bentham Science Publishers
www.bentham.org

  Copyright © 1994 - 2010   Bentham Science Publishers Ltd.